8-Isoprostane as a Biomarker of Oxidative Stress in Interstitial Lung Diseases

Oxidative stress contributes to the pathophysiology of interstitial lung diseases, such as cryptogenic fibrosing alveolitis (CFA), fibrosing alveolitis associated with systemic sclerosis (FASSc) and sarcoidosis. F2-isoprostanes are a series of prostaglandin (PG) F2-like compounds produced in vivo independent of cyclooxygenase, as products of the radical-catalyzed lipid peroxidation. Measurement of the concentrations of F2-isoprostanes has proved to be valuable in assessing oxidative stress in vivo. The aim of this study was to measure 8-epi-PGF2 α concentrations, one of the most abundant F2-isoprostane in humans, in bronchoalveolar lavage (BAL) in normal subjects and to compare them to those observed in patients with CFA (n = 9), FASSc (n = 8) and sarcoidosis (n = 10). 8-epi-PGF2 α was detectable in BAL fluid in normal subjects (9.6 ± 0.8 pg/ml) and its concentrations were increased approximately 5-fold in patients with CFA (47.4 ± 7.0, p < 0.001) and FASSc (43.2 ± 3.3, p < 0.001). 8-epi-PGF2 α was also increased in patients with sarcoidosis, although to a lesser extent (12.0 ± 0.70 pg/ml, p < 0.01). No correlation between 8-epi-PGF2 α and either lung function tests or BAL cell types was observed in any group of patients. Our study shows that the level of oxidative stress is enhanced in patients with interstitial lung diseases as reflected by increased concentrations of 8-epi-PGF2 α in BAL fluid.